Issues to Consider in Liquid Extraction Testing of Surfaces for Particulate Matter

Area of Science:

• Pharmaceutical Manufacturing
• Analytical Chemistry
• Biotechnology

Background:

• Pharmaceutical manufacturing involves contact between formulation ingredients, process fluids, and equipment surfaces.
• Maintaining surface cleanliness is essential for controlling particulate matter in final drug products, as required by good manufacturing practice (cGMP).
• Aseptic processes, like cell therapy, may not allow for filtration, increasing the risk of particulate accumulation and impacting drug purity.

Purpose of the Study:

• To address challenges in measuring surface cleanliness of pharmaceutical manufacturing equipment.
• To provide approaches for assessing and reporting surface cleanliness data.
• To support risk assessments for particulate matter control in drug manufacturing.

Main Methods:

• Discusses liquid extraction techniques for quantitative measurement of particulate matter on contact surfaces.
• Evaluates methods for assessing surface cleanliness.
• Outlines approaches for reporting surface cleanliness data.

Main Results:

• Quantitative measurement of particulate matter on contact surfaces is vital for risk assessment.
• Liquid extraction is a key method for assessing surface cleanliness.
• Standardized reporting of surface cleanliness is needed.

Conclusions:

• Accurate measurement and reporting of surface cleanliness are critical for ensuring pharmaceutical product quality and patient safety.
• Addressing challenges in surface cleanliness assessment is essential for aseptic and other pharmaceutical manufacturing processes.
• This work provides a foundation for improved particulate matter control strategies in drug manufacturing.